In this interview, we speak to Anas Al Zabiby, who discusses the growing role of multi-omics and AI in biomedical research.
Seer Inc. SEER on Thursday said its Proteograph Product Suite will serve as the mass spectrometry-based workflow to profile ...
Cancer doesn’t follow a linear path—it evolves, adapts, and forks. Even within a single tumor, individual cells behave differently. They mutate, diverge, and form heterogeneous clones that fuel ...
MultiKano is the first automatic cell type annotation method tailored to single-cell multi-omics data. MultiKano introduces a novel data augmentation strategy based on paired scRNA-seq and scATAC-seq ...
Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...
A high-throughput workflow integrates DNA methylation and RNA sequencing in single cells, enabling more complete insights ...
The immediate effects of climate change on ecology and the environment has significant downstream consequences to human health, agriculture, global security, infrastructure, biodiversity, and many ...
Profusa Inc. PFSA shares rose in Monday premarket trading after the company announced a $30 million Letter of Intent. The ...
Multifactorial diseases pose a significant global health challenge, impacting economically developed nations with conditions ...
Integrating proteomics with systems biology reveals complex cellular networks, improving disease mechanisms understanding and precision medicine applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results